Beijing Relpow Technology Balance Sheet Health
Financial Health criteria checks 5/6
Beijing Relpow Technology has a total shareholder equity of CN¥3.0B and total debt of CN¥968.6M, which brings its debt-to-equity ratio to 32.4%. Its total assets and total liabilities are CN¥4.4B and CN¥1.4B respectively.
Key information
32.4%
Debt to equity ratio
CN¥968.64m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥687.39m |
| Equity | CN¥2.99b |
| Total liabilities | CN¥1.45b |
| Total assets | CN¥4.43b |
Recent financial health updates
Is Beijing Relpow Technology (SZSE:300593) Using Debt Sensibly?
Aug 15
Beijing Relpow Technology (SZSE:300593) Seems To Use Debt Quite Sensibly
May 13Recent updates
Why Investors Shouldn't Be Surprised By Beijing Relpow Technology Co., Ltd's (SZSE:300593) 29% Share Price Surge
Nov 12Getting In Cheap On Beijing Relpow Technology Co., Ltd (SZSE:300593) Might Be Difficult
Sep 28Is Beijing Relpow Technology (SZSE:300593) Using Debt Sensibly?
Aug 15Beijing Relpow Technology (SZSE:300593) Has Announced That Its Dividend Will Be Reduced To CN¥0.10
May 23Beijing Relpow Technology (SZSE:300593) Seems To Use Debt Quite Sensibly
May 13Bearish: Analysts Just Cut Their Beijing Relpow Technology Co., Ltd (SZSE:300593) Revenue and EPS estimates
Apr 24Beijing Relpow Technology Co., Ltd Just Missed EPS By 66%: Here's What Analysts Think Will Happen Next
Apr 23Why Investors Shouldn't Be Surprised By Beijing Relpow Technology Co., Ltd's (SZSE:300593) 32% Share Price Surge
Mar 06Financial Position Analysis
Short Term Liabilities: 300593's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥893.5M).
Long Term Liabilities: 300593's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥553.3M).
Debt to Equity History and Analysis
Debt Level: 300593's net debt to equity ratio (9.4%) is considered satisfactory.
Reducing Debt: 300593's debt to equity ratio has reduced from 44% to 32.4% over the past 5 years.
Debt Coverage: 300593's debt is well covered by operating cash flow (22.2%).
Interest Coverage: Insufficient data to determine if 300593's interest payments on its debt are well covered by EBIT.